Syndros THC Oral Solution Now FDA Approved Schedule II
Listen now
Description
The U.S. Drug Enforcement Administration has placed the Syndros THC oral solution under Schedule II via FDA Approval.
More Episodes
Governor Lays Out Requirements for Vermont Legalization; Tim Hade on Micro-Grid Energy solutions for cannabis cultivation.
Published 05/26/17
America's District Attorneys endorse crackdown on marijuana. Plus, Amanda Feilding on the Future of Psychedelic Medicine from Psychedelic Science 2017.
Published 05/26/17
Today on The Marijuana Agenda, Trump's Budget includes largest requests ever for High Intensity Drug Trafficking Areas (HIDTA) and Drug-Free Communities Grants. Amanda Fielding on the Future of Psychedelic Medicine from Psychedelic Science 2017. New paper examines legalization's effect on...
Published 05/26/17